Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 27, 2023 Filed Mar 29, 2023 21:51 UTC |
Heino Mary AnneDirector · CEO
|
SaleCommon Stock | 28,662 | $80.47 | $2,306,525.72 |
DisclosureSEC source: 0000899243-23-009990 · doc4.xml · nonDerivative · entry 2 Heino Mary Anne · CIK 0001610676 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Common Stock Disclosed balance after: 435,219 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.89 to $80.88, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| March 27, 2023 Filed Mar 29, 2023 21:51 UTC |
Heino Mary AnneDirector · CEO
|
Exercise / conversionCommon Stock | 44,484 | $19.11 | $850,089.24 |
DisclosureSEC source: 0000899243-23-009990 · doc4.xml · nonDerivative · entry 1 Heino Mary Anne · CIK 0001610676 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Common Stock Disclosed balance after: 463,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023. F2 · balance_after: On March 10, 2023, the reporting person transferred 300,000 shares of LNTH common stock to a Grantor Retained Annuity Trust of which the reporting person's spouse is a trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 16:30 UTC |
Sabens AndreaChief Accounting Officer
|
SaleCommon Stock | 386 | $71.58 | $27,629.88 |
DisclosureSEC source: 0000899243-23-008877 · doc4.xml · nonDerivative · entry 1 Sabens Andrea · CIK 0001876279 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,290 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:30 UTC |
Marshall Robert J. Jr.CFO and Treasurer
|
SaleCommon Stock | 5,000 | $71.58 | $357,900.00 |
DisclosureSEC source: 0000899243-23-008878 · doc4.xml · nonDerivative · entry 1 Marshall Robert J. Jr. · CIK 0001754976 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,298 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 22:08 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 4,744 | $75.29 | $357,169.12 |
DisclosureSEC source: 0000899243-23-008147 · doc4.xml · nonDerivative · entry 2 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 719,397 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.82 to $75.69, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 22:08 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 5,320 | $74.18 | $394,624.30 |
DisclosureSEC source: 0000899243-23-008147 · doc4.xml · nonDerivative · entry 1 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724,141 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.75 to $74.69, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 18:44 UTC |
Sabens AndreaChief Accounting Officer
|
SaleCommon Stock | 950 | $72.15 | $68,546.30 |
DisclosureSEC source: 0000899243-23-007597 · doc4.xml · nonDerivative · entry 2 Sabens Andrea · CIK 0001876279 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,676 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 18:45 UTC |
Montagut EtienneChief Business Officer
|
SaleCommon Stock | 3,531 | $72.15 | $254,775.77 |
DisclosureSEC source: 0000899243-23-007600 · doc4.xml · nonDerivative · entry 2 Montagut Etienne · CIK 0001861389 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,294 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 23:44 UTC |
Niedzwiecki DanielSee Remarks
|
SaleCommon Stock | 1,055 | $72.15 | $76,122.47 |
DisclosureSEC source: 0000899243-23-007598 · doc4.xml · nonDerivative · entry 2 Niedzwiecki Daniel · CIK 0001861113 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,870 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 18:47 UTC |
Blanchfield PaulChief Operating Officer
|
SaleCommon Stock | 2,758 | $72.15 | $199,000.73 |
DisclosureSEC source: 0000899243-23-007602 · doc4.xml · nonDerivative · entry 2 Blanchfield Paul · CIK 0001801395 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,343 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 23:46 UTC |
Marshall Robert J. Jr.CFO and Treasurer
|
SaleCommon Stock | 4,854 | $72.15 | $350,235.52 |
DisclosureSEC source: 0000899243-23-007601 · doc4.xml · nonDerivative · entry 2 Marshall Robert J. Jr. · CIK 0001754976 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,298 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 02:09 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 12,189 | $73.24 | $892,771.12 |
DisclosureSEC source: 0000899243-23-007259 · doc4.xml · nonDerivative · entry 5 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729,461 F3 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transaction reported in this Form 4 was effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.69 to $72.6, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 18:44 UTC |
Sabens AndreaChief Accounting Officer
|
SaleCommon Stock | 7,705 | $72.56 | $559,082.51 |
DisclosureSEC source: 0000899243-23-007597 · doc4.xml · nonDerivative · entry 1 Sabens Andrea · CIK 0001876279 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,626 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 18:45 UTC |
Montagut EtienneChief Business Officer
|
SaleCommon Stock | 14,179 | $72.56 | $1,028,842.42 |
DisclosureSEC source: 0000899243-23-007600 · doc4.xml · nonDerivative · entry 1 Montagut Etienne · CIK 0001861389 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,825 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 23:44 UTC |
Niedzwiecki DanielSee Remarks
|
SaleCommon Stock | 9,079 | $72.56 | $658,781.32 |
DisclosureSEC source: 0000899243-23-007598 · doc4.xml · nonDerivative · entry 1 Niedzwiecki Daniel · CIK 0001861113 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,925 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 18:47 UTC |
Blanchfield PaulChief Operating Officer
|
SaleCommon Stock | 5,250 | $72.56 | $380,945.25 |
DisclosureSEC source: 0000899243-23-007602 · doc4.xml · nonDerivative · entry 1 Blanchfield Paul · CIK 0001801395 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,101 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 23:46 UTC |
Marshall Robert J. Jr.CFO and Treasurer
|
SaleCommon Stock | 20,587 | $72.56 | $1,493,813.31 |
DisclosureSEC source: 0000899243-23-007601 · doc4.xml · nonDerivative · entry 1 Marshall Robert J. Jr. · CIK 0001754976 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,152 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:09 UTC |
Sabens AndreaChief Accounting Officer
|
GrantCommon Stock | 7,099 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007262 · doc4.xml · nonDerivative · entry 2 Sabens Andrea · CIK 0001876279 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,331 F2 · kind: The transaction reported in this Form 4 reflects additional shares of common stock issued by the Company to the reporting person upon the vesting of relative Total Shareholder Return PSUs that were previously granted and included in the Form 3 filed upon the reporting person becoming a Section 16 officer. The number of shares reported in the Form 3 reflected 100% of the target number of shares underlying the PSUs. The number of shares that actually vested under the PSUs equaled 200% of the target number of shares. Accordingly, the number of shares reported in this Form 4 reflects the difference between the number of shares that actually vested under the PSUs and the target number of shares originally included in the Form 3. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:12 UTC |
Montagut EtienneChief Business Officer
|
GrantCommon Stock | 12,361 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007266 · doc4.xml · nonDerivative · entry 2 Montagut Etienne · CIK 0001861389 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,004 F2 · kind: The transaction reported in this Form 4 reflects additional shares of common stock issued by the Company to the reporting person upon the vesting of relative Total Shareholder Return PSUs that were previously granted and included in the Form 3 filed upon the reporting person becoming a Section 16 officer. The number of shares reported in the Form 3 reflected 100% of the target number of shares underlying the PSUs. The number of shares that actually vested under the PSUs equaled 200% of the target number of shares. Accordingly, the number of shares reported in this Form 4 reflects the difference between the number of shares that actually vested under the PSUs and the target number of shares originally included in the Form 3. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 02:10 UTC |
Niedzwiecki DanielSee Remarks
|
GrantCommon Stock | 7,515 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007264 · doc4.xml · nonDerivative · entry 2 Niedzwiecki Daniel · CIK 0001861113 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,004 F2 · kind: The transaction reported in this Form 4 reflects additional shares of common stock issued by the Company to the reporting person upon the vesting of relative Total Shareholder Return PSUs that were previously granted and included in the Form 3 filed upon the reporting person becoming a Section 16 officer. The number of shares reported in the Form 3 reflected 100% of the target number of shares underlying the PSUs. The number of shares that actually vested under the PSUs equaled 200% of the target number of shares. Accordingly, the number of shares reported in this Form 4 reflects the difference between the number of shares that actually vested under the PSUs and the target number of shares originally included in the Form 3. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 02:17 UTC |
Marshall Robert J. Jr.CFO and Treasurer
|
GrantCommon Stock | 17,391 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007268 · doc4.xml · nonDerivative · entry 2 Marshall Robert J. Jr. · CIK 0001754976 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,739 F2 · kind: The transaction reported in this Form 4 reflects additional shares of common stock issued by the Company to the reporting person upon the vesting of relative Total Shareholder Return PSUs that were previously granted and included in the Form 4 filed on March 5, 2020. The number of shares reported in the Form 4 reflected 100% of the target number of shares underlying the PSUs. The number of shares that actually vested under the PSUs equaled 200% of the target number of shares. Accordingly, the number of shares reported in this Form 4 reflects the difference between the number of shares that actually vested under the PSUs and the target number of shares originally included in the Form 4. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 02:09 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 17,397 | $73.35 | $1,276,111.70 |
DisclosureSEC source: 0000899243-23-007259 · doc4.xml · nonDerivative · entry 4 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741,650 F3 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transaction reported in this Form 4 was effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.14 to $73.99, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 02:09 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 64,658 | $72.90 | $4,713,542.34 |
DisclosureSEC source: 0000899243-23-007259 · doc4.xml · nonDerivative · entry 3 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,047 F3 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transaction reported in this Form 4 was effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.14 to $73.135, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 02:09 UTC |
Heino Mary AnneDirector · President & CEO
|
GrantCommon Stock | 74,486 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007259 · doc4.xml · nonDerivative · entry 2 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823,705 F2 · kind: The transaction reported in this Form 4 reflects additional shares of common stock issued by the Company to the reporting person upon the vesting of relative Total Shareholder Return PSUs that were previously granted and included in the Form 4 filed on March 5, 2020. The number of shares reported in the Form 4 reflected 100% of the target number of shares underlying the PSUs. The number of shares that actually vested under the PSUs equaled 200% of the target number of shares. Accordingly, the number of shares reported in this Form 4 reflects the difference between the number of shares that actually vested under the PSUs and the target number of shares originally included in the Form 4. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:09 UTC |
Sabens AndreaChief Accounting Officer
|
GrantStock Option (right to buy) · Derivative | 1,936 | $0.00 Strike: $73.35 | $0.00 |
DisclosureSEC source: 0000899243-23-007262 · doc4.xml · derivative · entry 3 Sabens Andrea · CIK 0001876279 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,936 Underlying: Common Stock · 1,936 shares Expires 2033-03-02 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 2, 2024. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:09 UTC |
Sabens AndreaChief Accounting Officer
|
GrantCommon Stock | 3,772 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007262 · doc4.xml · nonDerivative · entry 1 Sabens Andrea · CIK 0001876279 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,232 F1 · kind: Consists of 1,557 restricted stock units that vest in equal installments over a three-year period and 2,215 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award, however the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:12 UTC |
Montagut EtienneChief Business Officer
|
GrantStock Option (right to buy) · Derivative | 8,141 | $0.00 Strike: $73.35 | $0.00 |
DisclosureSEC source: 0000899243-23-007266 · doc4.xml · derivative · entry 3 Montagut Etienne · CIK 0001861389 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,141 Underlying: Common Stock · 8,141 shares Expires 2033-03-02 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 2, 2024. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:12 UTC |
Montagut EtienneChief Business Officer
|
GrantCommon Stock | 13,968 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007266 · doc4.xml · nonDerivative · entry 1 Montagut Etienne · CIK 0001861389 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,643 F1 · kind: Consists of 4,656 restricted stock units that vest in equal installments over a three-year period and 9,312 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award, however the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period. Read SEC document |
| March 02, 2023 Filed Mar 7, 2023 02:10 UTC |
Niedzwiecki DanielSee Remarks
|
GrantStock Option (right to buy) · Derivative | 7,196 | $0.00 Strike: $73.35 | $0.00 |
DisclosureSEC source: 0000899243-23-007264 · doc4.xml · derivative · entry 3 Niedzwiecki Daniel · CIK 0001861113 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,196 Underlying: Common Stock · 7,196 shares Expires 2033-03-02 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 2, 2024. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:10 UTC |
Blanchfield PaulChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 11,880 | $0.00 Strike: $73.35 | $0.00 |
DisclosureSEC source: 0000899243-23-007263 · doc4.xml · derivative · entry 2 Blanchfield Paul · CIK 0001801395 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,880 Underlying: Common Stock · 11,880 shares Expires 2033-03-02 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 2, 2024. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:10 UTC |
Blanchfield PaulChief Operating Officer
|
GrantCommon Stock | 20,383 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007263 · doc4.xml · nonDerivative · entry 1 Blanchfield Paul · CIK 0001801395 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,351 F1 · kind: Consists of 6,794 restricted stock units that vest in equal installments over a three-year period and 13,589 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award, however the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period. Read SEC document |
| March 02, 2023 Filed Mar 7, 2023 02:17 UTC |
Marshall Robert J. Jr.CFO and Treasurer
|
GrantStock Option (right to buy) · Derivative | 11,822 | $0.00 Strike: $73.35 | $0.00 |
DisclosureSEC source: 0000899243-23-007268 · doc4.xml · derivative · entry 3 Marshall Robert J. Jr. · CIK 0001754976 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,822 Underlying: Common Stock · 11,822 shares Expires 2033-03-02 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 2, 2024. Read SEC document |
| March 02, 2023 Filed Mar 7, 2023 02:17 UTC |
Marshall Robert J. Jr.CFO and Treasurer
|
GrantCommon Stock | 20,283 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007268 · doc4.xml · nonDerivative · entry 1 Marshall Robert J. Jr. · CIK 0001754976 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,348 F1 · kind: Consists of 6,761 restricted stock units that vest in equal installments over a three-year period and 13,522 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award, however the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period. Read SEC document |
| March 02, 2023 Filed Mar 7, 2023 02:11 UTC |
Provost Jean-ClaudeChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 9,535 | $0.00 Strike: $73.35 | $0.00 |
DisclosureSEC source: 0000899243-23-007265 · doc4.xml · derivative · entry 2 Provost Jean-Claude · CIK 0001960060 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Theranostics Consulting SAS Disclosed balance after: 9,535 Underlying: Common Stock · 9,535 shares Expires 2033-03-02 F2 · shares: The reporting person is the managing partner of the company that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 2, 2024. Read SEC document |
| March 02, 2023 Filed Mar 7, 2023 02:11 UTC |
Provost Jean-ClaudeChief Medical Officer
|
GrantCommon Stock | 16,359 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007265 · doc4.xml · nonDerivative · entry 1 Provost Jean-Claude · CIK 0001960060 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Theranostics Consulting SAS Disclosed balance after: 20,823 F1 · kind: Consists of 5,453 restricted stock units that vest in equal installments over a three-year period and 10,906 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award, however the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period. F2 · shares: The reporting person is the managing partner of the company that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| March 02, 2023 Filed Mar 7, 2023 02:09 UTC |
Heino Mary AnneDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 44,696 | $0.00 Strike: $73.35 | $0.00 |
DisclosureSEC source: 0000899243-23-007259 · doc4.xml · derivative · entry 6 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,696 Underlying: Common Stock · 44,696 shares Expires 2033-03-02 F7 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 2, 2024. Read SEC document |
| March 02, 2023 Filed Mar 7, 2023 02:09 UTC |
Heino Mary AnneDirector · President & CEO
|
GrantCommon Stock | 76,686 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007259 · doc4.xml · nonDerivative · entry 1 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749,219 F1 · kind: Consists of 25,562 restricted stock units that vest in equal installments over a three-year period and 51,124 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award, however the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 16:30 UTC |
Sabens AndreaChief Accounting Officer
|
SaleCommon Stock | 386 | $57.52 | $22,202.72 |
DisclosureSEC source: 0000899243-23-005474 · doc4.xml · nonDerivative · entry 1 Sabens Andrea · CIK 0001876279 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,460 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 16:45 UTC |
Sabens AndreaChief Accounting Officer
|
SaleCommon Stock | 386 | $52.97 | $20,446.42 |
DisclosureSEC source: 0000899243-23-002168 · doc4.xml · nonDerivative · entry 1 Sabens Andrea · CIK 0001876279 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,846 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2023. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 16:31 UTC |
Sabens AndreaChief Accounting Officer
|
SaleCommon Stock | 386 | $53.75 | $20,747.50 |
DisclosureSEC source: 0000899243-22-038990 · doc4.xml · nonDerivative · entry 1 Sabens Andrea · CIK 0001876279 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,232 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 16:30 UTC |
Blanchfield PaulChief Operating Officer
|
SaleCommon Stock | 2,432 | $54.79 | $133,249.28 |
DisclosureSEC source: 0000899243-22-036517 · doc4.xml · nonDerivative · entry 1 Blanchfield Paul · CIK 0001801395 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,968 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2022. F2 · balance_after: Includes 257 shares acquired under the LNTH employee stock purchase plan on September 16, 2022. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 16:30 UTC |
Sabens AndreaChief Accounting Officer
|
SaleCommon Stock | 386 | $59.00 | $22,774.00 |
DisclosureSEC source: 0000899243-22-036190 · doc4.xml · nonDerivative · entry 1 Sabens Andrea · CIK 0001876279 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,618 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:30 UTC |
Marshall Robert J. Jr.CFO and Treasurer
|
SaleCommon Stock | 5,000 | $59.00 | $295,000.00 |
DisclosureSEC source: 0000899243-22-036191 · doc4.xml · nonDerivative · entry 1 Marshall Robert J. Jr. · CIK 0001754976 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,065 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 21:30 UTC |
Niedzwiecki DanielSee Remarks
|
SaleCommon Stock | 3,000 | $59.73 | $179,190.00 |
DisclosureSEC source: 0000899243-22-035872 · doc4.xml · nonDerivative · entry 1 Niedzwiecki Daniel · CIK 0001861113 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,143 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2022. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 21:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 1,516 | $58.58 | $88,802.73 |
DisclosureSEC source: 0000899243-22-035521 · doc4.xml · nonDerivative · entry 4 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 672,533 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.38 to $58.97, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 21:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 4,884 | $57.86 | $282,570.17 |
DisclosureSEC source: 0000899243-22-035521 · doc4.xml · nonDerivative · entry 3 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 674,049 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.36 to $58.35, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 21:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 4,750 | $56.66 | $269,115.05 |
DisclosureSEC source: 0000899243-22-035521 · doc4.xml · nonDerivative · entry 2 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 678,933 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.36 to $57.31, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 21:30 UTC |
Heino Mary AnneDirector · President & CEO
|
SaleCommon Stock | 2,000 | $55.94 | $111,877.40 |
DisclosureSEC source: 0000899243-22-035521 · doc4.xml · nonDerivative · entry 1 Heino Mary Anne · CIK 0001610676 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,683 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.36 to $56.33, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., ("LNTH"), any security holder of LNTH, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| October 19, 2022 Filed Oct 20, 2022 16:30 UTC |
Montagut EtienneChief Business Officer
|
SaleCommon Stock | 3,324 | $71.81 | $238,696.44 |
DisclosureSEC source: 0000899243-22-033884 · doc4.xml · nonDerivative · entry 2 Montagut Etienne · CIK 0001861389 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,675 F3 · kind: This transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022. Read SEC document |
| October 18, 2022 Filed Oct 20, 2022 16:30 UTC |
Montagut EtienneChief Business Officer
|
SaleCommon Stock | 2,536 | $73.41 | $186,177.90 |
DisclosureSEC source: 0000899243-22-033884 · doc4.xml · nonDerivative · entry 1 Montagut Etienne · CIK 0001861389 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,999 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transaction reported in this Form 4 was effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F2 · balance_after: Includes 345 shares acquired under the LNTH employee stock purchase plan on March 11, 2022 and 215 shares acquired under the LNTH employee stock purchase plan on September 16, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.